COMMUNIQUÉS West-GlobeNewswire

Avivagen Chairman and CEO Kym Anthony, Joins Everett Jolly Uptick Newswire’s “Stock Day” Podcast
17/07/2018
PHOENIX, July 17, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire, today announced the interview of Avivagen Chairman and CEO Kym Anthony on Stock Day Podcast with Everett Jolly. Avivagen’s scientifically backed, evidence- [...]
Oxford Immunotec Schedules Second Quarter 2018 Earnings Release and Conference Call for July 31, 2018
17/07/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release second [...]
Avid Bioservices Announces Appointment of Daniel Hart as Chief Financial Officer
17/07/2018
-- Senior Executive with Extensive Financial Leadership Experience Further Strengthens Management Team; Company Also Adds Senior Director of Business Development for Western Region to Support Client Acquisition Efforts [...]
Samumed to Present Preclinical Data on SM07883, a Potential First-in-Class Alzheimer’s Disease Candidate, at the Alzheimer’s Association International Conference® (AAIC®) 2018
17/07/2018
SAN DIEGO, July 17, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has been selected to present preclinical data on the company’s novel DYRK1a inhibitor, SM07883, a potential first-in-class drug for the [...]
Yield10 Bioscience Researcher Dr. Frank Skraly to Present at the Plant Biology 2018 Conference
17/07/2018
WOBURN, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, announced [...]
Inspire Medical Systems, Inc. to Report Second Quarter 2018 Financial Results August 7, 2018
17/07/2018
MINNEAPOLIS, July 17, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (“Inspire”) (NYSE:INSP), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer
17/07/2018
The Former CEO, Dr. Hans Loibner, Will Continue to Support the Company as Senior Advisor VIENNA, Austria, July 17, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, today [...]
PotNetwork Holdings, Inc., With Sales of Over $10 Million Year-To-Date, Moves Toward Uplisting and Expansion
17/07/2018
FT. LAUDERDALE, Fla., July 17, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holdings, Inc. (OTC Pink:POTN) on July 13 th , the Company announced that it had filed a Form 10 registration statement with the [...]
Transactions in relation to share buyback program
17/07/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Crenezumab's Second Phase 3 Trial (CREAD 2) Fully Recruited - Updates on AC Immune's Pipeline and Technology Platforms to be presented at AAIC in Chicago
17/07/2018
Crenezumab's Second Phase 3 Trial (CREAD 2) Fully Recruited - Updates on AC Immune's Pipeline and Technology Platforms to be presented at the Alzheimer's Association International Conference in Chicago Lausanne, [...]
Enzymatica AB: Lower sales in Q2 but 31% increase for the first half of the year
17/07/2018
Interim report for Enzymatica AB (publ) JANUARY-JUNE 2018 Lower sales in Q2 but 31% increase for the first half of the year Q2 Net sales reached SEK 5.3 (5.9) million. Net profit after tax came in at SEK -15.5 (-10.8) [...]
CellaVision AB: Interim Report January-June 2018
17/07/2018
Good sales growth in all regions April 1-June 30, 2018 Net sales increased by 17% to SEK 91.9 million (78.7). Organic growth was 15%. Operating profit was SEK 31.6 million (24.6). Operating margin was 34.4% (31.3). [...]
Terveystalo Plc: The Finnish Competition and Consumer Authority initiates further proceedings concerning the transaction between Terveystalo and Attendo
17/07/2018
Terveystalo Plc Stock Exchange release 17 July 2018 at 09.00 a.m. EEST Terveystalo Plc ("Terveystalo") has on 17 May 2018 signed an agreement to acquire the Finnish healthcare operations of Attendo AB (publ) ("Attendo [...]
Shire plc : Rule 2.9 Announcement
17/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 17 July 2018 Shire [...]
Nicox : Point d'activité et résumé financier du second trimestre 2018
17/07/2018
Communiqué de presse Nicox : Point d'activité et résumé financier du second trimestre 2018 .............................................. 17 juillet 2018 - diffusion à 7h30 Sophia Antipolis, France Nicox SA (Euronext [...]
Nicox Second Quarter 2018 Business Update and Financial Highlights
17/07/2018
Press Release Nicox Second Quarter 2018 Business Update and Financial Highlights .............................................. July 17, 2018 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: [...]
argenx receives milestone payment from strategic collaboration with Shire
17/07/2018
July 17, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Biocartis Group NV: Biocartis launches innovative Idylla(TM) MSI Assay
17/07/2018
PRESS RELEASE : 17 July 2018, 07:00 CEST Biocartis launches innovative Idylla(TM) MSI Assay Idylla(TM) MSI Assay further strengthens Biocartis' test menu and offers opportunities to enter the immuno-oncology testing [...]
Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/07/2018
WALTHAM, Mass., July 16, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Compensation Committee of the Company’s Board of Directors granted Chhaya Shah, in [...]

Pages